INS and Hypoglycemia: Strikingly, the insulin-evoked increase in plasma glucagon levels was abolished after pretreatment of WT mice with a selective V1bR antagonist (SSR149415; Figure 7C), indicating that AVP-dependent activation of V1bRs plays a key role in the compensatory increase in glucagon release following insulin-induced hypoglycemia.